UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ 16,855	$ 7,616
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (benefit) for credit losses	(1,635)	10,777
Loss on sale of assets	82	0
Loss on impairment of intangible assets	209	5,771
Right-of-use amortization and cease use costs	143	339
Amortization of debt issuance costs	850	775
Deferred income taxes, net	4,156	2,100
Unrealized net gain on warrants	(2,563)	(178)
Loss on disposal of inventory	314	0
Net gain from exercise and cancellation of warrants	0	(444)
Gain on sale of business	(1,476)	0
Change in fair value of acquisition-related contingent consideration	0	(4,900)
Loss (gain) on revaluation of finance receivables	3,727	(2,495)
Foreign currency transaction gains	(639)	(678)
Loss on marketable investments	314	168
Loan discount amortization and fee accretion	(5,961)	(2,461)
Interest paid-in-kind	(1,582)	(1,359)
Stock-based compensation	894	708
Depreciation and amortization expense	40	1,169
Changes in operating assets and liabilities:
Interest, accounts receivable and other receivables	207	(1,691)
Foreign currency forward contract	915	219
Collateral returned for foreign currency forward contract	2,750	0
Other assets	1,274	30
Accounts payable, accrued expenses, and other non-current liabilities	(387)	(1,406)
Deferred income	(1,500)	2,100
Net cash provided by operating activities	16,987	16,160
Cash flows from investing activities:
Proceeds from sale of property and equipment	110	0
Settlement of foreign currency forward contract	1,560	0
Proceeds from sale of assets and liabilities held for sale	6,790	0
Sale of marketable investments	0	574
Investment in finance receivables	(28,500)	(17,736)
Proceeds from sale of finance receivables	31,678	0
Repayment of finance receivables	34,651	30,582
Corporate debt securities principal payments	23	20
Purchases of property and equipment	(512)	(50)
Net cash provided by investing activities	45,800	13,390
Cash flows from financing activities:
Net settlement for employee taxes on stock options	(89)	(43)
Net payments on credit facility	(6,233)	(12,350)
Cash dividends	(49,078)	0
Payments of financing costs	(41)	(50)
Repurchases of common stock, including fees and expenses	(3,067)	(5,165)
Net cash used in financing activities	(58,508)	(17,608)
Net increase in cash and cash equivalents	4,279	11,942
Cash and cash equivalents at beginning of period	5,927	5,236
Cash and cash equivalents at end of period	10,206	17,178
Fair value of warrants received with finance receivables	0	1,073
Supplemental non-cash investing and financing activities:
Fair value of warrants received with finance receivables	0	1,073
Cash paid for interest	2,259	2,403
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	$ 0	$ 82